Gabelli Healthcare & WellnessRx Trust
CIK: 0001391437
GRX
Equity
About this Fund
The Gabelli Healthcare & WellnessRx Trust is a renowned mutual fund company that specializes in providing a diverse range of investment solutions to discerning investors seeking to capitalize on the growth potential of the healthcare and wellness sector. As a leading player in the asset management industry, the company offers a carefully crafted portfolio of mutual funds that cater to the unique needs and risk tolerance of its clients, including equity, debt, and hybrid funds that enable investors to navigate the complexities of the market with confidence. With a strong focus on wealth management, the Gabelli Healthcare & WellnessRx Trust is dedicated to helping its investors achieve their long-term financial goals through a combination of strategic investment planning, rigorous research, and expert portfolio management. By leveraging its extensive expertise and experience in the healthcare and wellness space, the company is able to identify emerging trends and opportunities that can help drive returns for its investors, whether they are seeking to invest through a systematic investment plan (SIP) or make a lump sum investment. The Gabelli Healthcare & WellnessRx Trust's investor-centric approach is built around a deep understanding of the needs and aspirations of its clients, who trust the company to manage their investments with integrity, transparency, and a unwavering commitment to excellence. With its specialist knowledge of the healthcare and wellness sector, the company is well-positioned to help its investors capitalize on the sector's growth potential, which is driven by an increasing demand for innovative healthcare solutions, an aging population, and a growing focus on wellness and preventive care. By investing in the Gabelli Healthcare & WellnessRx Trust, investors can gain access to a diversified portfolio of securities that are carefully selected to balance risk and potential returns, while also benefiting from the company's robust investment process, which combines fundamental research, quantitative analysis, and a disciplined approach to risk management. As a trusted partner to its investors, the Gabelli Healthcare & WellnessRx Trust is dedicated to delivering exceptional investment performance, outstanding client service, and a comprehensive range of wealth management solutions that can help its clients achieve financial peace of mind and secure their financial future. With its strong track record of investment expertise and its unwavering commitment to putting the needs of its clients first, the Gabelli Healthcare & WellnessRx Trust has established itself as a leading mutual fund company that investors can trust to manage their investments with skill, precision, and a deep understanding of the complexities of the healthcare and wellness sector.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | OSCR Oscar Health Inc Since 2026-05-10 | 687793109 | Equity (Common) |
0.01%
|
$0.02 | 1,600 |
| 2 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
1.39%
|
$2.21 | 17,600 |
| 3 | EVH Evolent Health Inc Since 2026-05-10 | 30050B101 | Equity (Common) |
0.19%
|
$0.31 | 76,500 |
| 4 | NKTR Nektar Therapeutics Since 2026-05-10 | 640268306 | Equity (Common) |
0.05%
|
$0.07 | 1,750 |
| 5 | LW Lamb Weston Holdings Inc Since 2026-05-10 | 513272104 | Equity (Common) |
0.26%
|
$0.42 | 10,000 |
| 6 | HQY HealthEquity Inc Since 2026-05-10 | 42226A107 | Equity (Common) |
0.05%
|
$0.07 | 800 |
| 7 | GMED Globus Medical Inc Since 2026-05-10 | 379577208 | Equity (Common) |
0.41%
|
$0.66 | 7,500 |
| 8 | ZYME Zymeworks Inc Since 2026-05-10 | 98985Y108 | Equity (Common) |
0.04%
|
$0.07 | 2,500 |
| 9 | ICUI ICU Medical Inc Since 2026-05-10 | 44930G107 | Equity (Common) |
0.90%
|
$1.43 | 10,000 |
| 10 | MDGL Madrigal Pharmaceuticals Inc Since 2026-05-10 | 558868105 | Equity (Common) |
0.11%
|
$0.17 | 300 |
| 11 | EBS Emergent BioSolutions Inc Since 2026-05-10 | 29089Q105 | Equity (Common) |
0.05%
|
$0.09 | 7,000 |
| 12 | GRAL GRAIL Inc Since 2026-05-10 | 384747101 | Equity (Common) |
0.10%
|
$0.15 | 1,800 |
| 13 | COR Cencora Inc Since 2026-05-10 | 03073E105 | Equity (Common) |
2.15%
|
$3.41 | 10,100 |
| 14 | POST Post Holdings Inc Since 2026-05-10 | 737446104 | Equity (Common) |
2.18%
|
$3.47 | 35,000 |
| 15 | HNGE Hinge Health Inc Since 2026-05-10 | 433313103 | Equity (Common) |
0.05%
|
$0.09 | 1,850 |
| 16 | SFM Sprouts Farmers Market Inc Since 2026-05-10 | 85208M102 | Equity (Common) |
0.50%
|
$0.80 | 10,000 |
| 17 | CHD Church & Dwight Co Inc Since 2026-05-10 | 171340102 | Equity (Common) |
0.63%
|
$1.01 | 12,000 |
| 18 | HSIC Henry Schein Inc Since 2026-05-10 | 806407102 | Equity (Common) |
1.32%
|
$2.09 | 27,700 |
| 19 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
1.00%
|
$1.59 | 16,600 |
| 20 | SYRE Spyre Therapeutics Inc Since 2026-05-10 | 00773J202 | Equity (Common) |
0.01%
|
$0.01 | 300 |
| 21 | RCEL Avita Medical Inc Since 2026-05-10 | 05380C102 | Equity (Common) |
0.06%
|
$0.09 | 26,500 |
| 22 | TVTX Travere Therapeutics Inc Since 2026-05-10 | 89422G107 | Equity (Common) |
0.10%
|
$0.15 | 4,000 |
| 23 | DYN Dyne Therapeutics Inc Since 2026-05-10 | 26818M108 | Equity (Common) |
0.01%
|
$0.02 | 880 |
| 24 | BLLN Billiontoone Inc Since 2026-05-10 | 090168105 | Equity (Common) |
0.01%
|
$0.02 | 205 |
| 25 | LNTH Lantheus Holdings Inc Since 2026-05-10 | 516544103 | Equity (Common) |
1.00%
|
$1.60 | 24,000 |
| 26 | ILMN Illumina Inc Since 2026-05-10 | 452327109 | Equity (Common) |
0.30%
|
$0.47 | 3,600 |
| 27 | SPRY ARS Pharmaceuticals Inc Since 2026-05-10 | 82835W108 | Equity (Common) |
0.04%
|
$0.06 | 5,000 |
| 28 | BCAX Bicara Therapeutics Inc Since 2026-05-10 | 055477103 | Equity (Common) |
0.01%
|
$0.01 | 650 |
| 29 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
0.71%
|
$1.13 | 2,000 |
| 30 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
0.27%
|
$0.43 | 3,500 |
| 31 | VIVS VivoSim Labs Inc Since 2026-05-10 | 68620A302 | Equity (Common) |
0.00%
|
$0.01 | 3,333 |
| 32 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
0.54%
|
$0.85 | 1,105 |
| 33 | AXSM Axsome Therapeutics Inc Since 2026-05-10 | 05464T104 | Equity (Common) |
0.11%
|
$0.18 | 1,000 |
| 34 | REPL Replimune Group Inc Since 2026-05-10 | 76029N106 | Equity (Common) |
0.05%
|
$0.08 | 8,500 |
| 35 | AVTR Avantor Inc Since 2026-05-10 | 05352A100 | Equity (Common) |
0.34%
|
$0.54 | 47,000 |
| 36 | DVA DaVita Inc Since 2026-05-10 | 23918K108 | Equity (Common) |
0.36%
|
$0.57 | 5,000 |
| 37 | OFIX Orthofix Medical Inc Since 2026-05-10 | 68752M108 | Equity (Common) |
0.12%
|
$0.19 | 12,500 |
| 38 | HALO Halozyme Therapeutics Inc Since 2026-05-10 | 40637H109 | Equity (Common) |
1.83%
|
$2.91 | 43,200 |
| 39 | INFU InfuSystem Holdings Inc Since 2026-05-10 | 45685K102 | Equity (Common) |
0.80%
|
$1.27 | 142,085 |
| 40 | BRBR BellRing Brands Inc Since 2026-05-10 | 07831C103 | Equity (Common) |
1.35%
|
$2.14 | 80,000 |
| 41 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
3.41%
|
$5.42 | 23,700 |
| 42 | VMD Viemed Healthcare Inc Since 2026-05-10 | 92663R105 | Equity (Common) |
0.40%
|
$0.63 | 85,000 |
| 43 | CELC Celcuity Inc Since 2026-05-10 | 15102K100 | Equity (Common) |
0.09%
|
$0.15 | 1,500 |
| 44 | LH Labcorp Holdings Inc Since 2026-05-10 | 504922105 | Equity (Common) |
1.18%
|
$1.88 | 7,500 |
| 45 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.13%
|
$0.20 | 900 |
| 46 | HIMS Hims & Hers Health Inc Since 2026-05-10 | 433000106 | Equity (Common) |
0.02%
|
$0.03 | 1,000 |
| 47 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
1.04%
|
$1.65 | 2,855 |
| 48 | ZVRA Zevra Therapeutics Inc Since 2026-05-10 | 488445206 | Equity (Common) |
0.02%
|
$0.03 | 3,000 |
| 49 | RVMD Revolution Medicines Inc Since 2026-05-10 | 76155X100 | Equity (Common) |
0.09%
|
$0.14 | 1,750 |
| 50 | CAH Cardinal Health Inc Since 2026-05-10 | 14149Y108 | Equity (Common) |
0.19%
|
$0.31 | 1,500 |
| 51 | SLNO Soleno Therapeutics Inc Since 2026-05-10 | 834203309 | Equity (Common) |
0.11%
|
$0.17 | 3,750 |
| 52 | IONS Ionis Pharmaceuticals Inc Since 2026-05-10 | 462222100 | Equity (Common) |
0.07%
|
$0.12 | 1,500 |
| 53 | IMNM Immunome Inc Since 2026-05-10 | 45257U108 | Equity (Common) |
0.06%
|
$0.09 | 4,250 |
| 54 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.01%
|
$0.01 | 200 |
| 55 | IDXX IDEXX Laboratories Inc Since 2026-05-10 | 45168D104 | Equity (Common) |
0.12%
|
$0.19 | 285 |
| 56 | VERA Vera Therapeutics Inc Since 2026-05-10 | 92337R101 | Equity (Common) |
0.08%
|
$0.13 | 2,500 |
| 57 | SGRY Surgery Partners Inc Since 2026-05-10 | 86881A100 | Equity (Common) |
0.39%
|
$0.62 | 40,397 |
| 58 | TARS Tarsus Pharmaceuticals Inc Since 2026-05-10 | 87650L103 | Equity (Common) |
0.09%
|
$0.15 | 1,800 |
| 59 | OPCH Option Care Health Inc Since 2026-05-10 | 68404L201 | Equity (Common) |
3.21%
|
$5.10 | 160,210 |
| 60 | BIO-B Bio-Rad Laboratories Inc Since 2026-05-10 | 090572207 | Equity (Common) |
0.67%
|
$1.06 | 3,500 |
| 61 | LUCD Lucid Diagnostics Inc Since 2026-05-10 | 54948X109 | Equity (Common) |
0.01%
|
$0.02 | 19,500 |
| 62 | PTGX Protagonist Therapeutics Inc Since 2026-05-10 | 74366E102 | Equity (Common) |
0.07%
|
$0.11 | 1,250 |
| 63 | BAX Baxter International Inc Since 2026-05-10 | 071813109 | Equity (Common) |
0.10%
|
$0.15 | 8,000 |
| 64 | WAY Waystar Holding Corp Since 2026-05-10 | 946784105 | Equity (Common) |
0.18%
|
$0.28 | 8,500 |
| 65 | PGNY Progyny Inc Since 2026-05-10 | 74340E103 | Equity (Common) |
0.08%
|
$0.12 | 4,800 |
| 66 | FLO Flowers Foods Inc Since 2026-05-10 | 343498101 | Equity (Common) |
0.21%
|
$0.33 | 30,000 |
| 67 | PFE Pfizer Inc Since 2026-05-10 | 717081103 | Equity (Common) |
0.50%
|
$0.80 | 32,100 |
| 68 | AZN AstraZeneca PLC Since 2026-05-10 | 046353108 | Equity (Common) |
1.76%
|
$2.80 | 30,500 |
| 69 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
1.63%
|
$2.59 | 7,900 |
| 70 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
0.14%
|
$0.22 | 550 |
| 71 | NEO NeoGenomics Inc Since 2026-05-10 | 64049M209 | Equity (Common) |
0.67%
|
$1.06 | 90,000 |
| 72 | ZTS Zoetis Inc Since 2026-05-10 | 98978V103 | Equity (Common) |
0.02%
|
$0.04 | 300 |
| 73 | BBIO Bridgebio Pharma Inc Since 2026-05-10 | 10806X102 | Equity (Common) |
1.97%
|
$3.14 | 41,000 |
| 74 | DNLI Denali Therapeutics Inc Since 2026-05-10 | 24823R105 | Equity (Common) |
0.00%
|
$0.01 | 400 |
| 75 | FDMT 4D Molecular Therapeutics Inc Since 2026-05-10 | 35104E100 | Equity (Common) |
0.06%
|
$0.09 | 12,000 |
| 76 | TGTX TG Therapeutics Inc Since 2026-05-10 | 88322Q108 | Equity (Common) |
0.02%
|
$0.03 | 850 |
| 77 | GH Guardant Health Inc Since 2026-05-10 | 40131M109 | Equity (Common) |
0.00%
|
$0.01 | 55 |
| 78 | ZBH Zimmer Biomet Holdings Inc Since 2026-05-10 | 98956P102 | Equity (Common) |
1.50%
|
$2.38 | 26,500 |
| 79 | BIIB Biogen Inc Since 2026-05-10 | 09062X103 | Equity (Common) |
0.14%
|
$0.23 | 1,300 |
| 80 | COGT Cogent Biosciences Inc Since 2026-05-10 | 19240Q201 | Equity (Common) |
0.08%
|
$0.12 | 3,500 |
| 81 | IDYA Ideaya Biosciences Inc Since 2026-05-10 | 45166A102 | Equity (Common) |
0.08%
|
$0.12 | 3,600 |
| 82 | ARQT Arcutis Biotherapeutics Inc Since 2026-05-10 | 03969K108 | Equity (Common) |
0.09%
|
$0.14 | 5,000 |
| 83 | PTCT PTC Therapeutics Inc Since 2026-05-10 | 69366J200 | Equity (Common) |
0.02%
|
$0.03 | 360 |
| 84 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
2.70%
|
$4.29 | 40,750 |
| 85 | CVGW Calavo Growers Inc Since 2026-05-10 | 128246105 | Equity (Common) |
0.07%
|
$0.11 | 5,000 |
| 86 | CRNX Crinetics Pharmaceuticals Inc Since 2026-05-10 | 22663K107 | Equity (Common) |
0.09%
|
$0.14 | 3,000 |
Frequently Asked Questions — Gabelli Healthcare & WellnessRx Trust
What type of mutual fund is Gabelli Healthcare & WellnessRx Trust?
Gabelli Healthcare & WellnessRx Trust is a SEC-registered Equity fund, with $159M in assets under management.
Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate.
As of its latest SEC N-PORT filing, Gabelli Healthcare & WellnessRx Trust holds 86 portfolio positions, all detailed in the holdings table on this page.
What are Gabelli Healthcare & WellnessRx Trust's assets under management (AUM)?
Gabelli Healthcare & WellnessRx Trust has $159M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting.
AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale.
AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are Gabelli Healthcare & WellnessRx Trust's top holdings?
According to Gabelli Healthcare & WellnessRx Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include
Oscar Health Inc,
Abbott Laboratories,
Evolent Health Inc
, among others.
The complete list of all 86 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above.
Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is Gabelli Healthcare & WellnessRx Trust's expense ratio?
Expense ratio data for Gabelli Healthcare & WellnessRx Trust is not currently available in StockSifting's database.
The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors.
For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find Gabelli Healthcare & WellnessRx Trust's SEC filings?
Gabelli Healthcare & WellnessRx Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001391437.
You can access all of Gabelli Healthcare & WellnessRx Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on
SEC EDGAR (CIK: 0001391437).
N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is Gabelli Healthcare & WellnessRx Trust's holdings data on StockSifting?
Holdings data for Gabelli Healthcare & WellnessRx Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing.
Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions.
The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released.
For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.